PEP News
Leprosy Diagnostic Working Group develops 2 target product profiles
19 July, 2021 | Global Partnership for Zero Leprosy
Despite available treatment, over 200,000 individuals were diagnosed with leprosy across more than 120 countries in 2019. Early detection of the disease can help prevent disability and the spread of infection. Detection rates could be improved with a tool that’s … More Leprosy Diagnostic Working Group develops 2 target product profiles
GPZL Secretariat Director discusses leprosy prevalence and prevention on Voice of America
2 March, 2021 | Global Partnership for Zero Leprosy
GPZL Secretariat Director, Bill Gallo, sat down with Linord Moudou, host of Voice of America’s Healthy Living series, to discuss leprosy prevalence and the new path toward prevention. The segment, “Fear and Loathing of Leprosy,” opens with perspectives of persons affected … More GPZL Secretariat Director discusses leprosy prevalence and prevention on Voice of America
New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years
2 March, 2021 | NLR International
To interrupt leprosy transmission and reduce annual new cases significantly, contact tracing and preventive treatment needs to be implemented in all leprosy-endemic countries Amsterdam, the Netherlands, March 1, 2021 – New research by NLR, until No Leprosy Remains (NLR) and Erasmus University … More New NLR study predicts 90% leprosy reduction through preventive treatment of 40 million people in 22 years
Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)
6 January, 2021 | ILEP Technical Commission
Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP), in light of recent information on nitrosamine impurities in rifampicin A number of different problems have affected the supply of rifampicin and MDT to countries this year. The most … More Interim advice on the use of rifampicin for post-exposure prophylaxis (PEP)
A Prioritized Zero Leprosy Research Agenda
4 November, 2020 | Global Partnership for Zero Leprosy
The Global Partnership for Zero Leprosy (GPZL) presented the prioritised Zero Leprosy Research Agenda at the WHO Global Consultation on Global Leprosy Strategy 2021 – 2030 last week. In 2018, the Research Agenda working group’s eight different sub-groups conducted a … More A Prioritized Zero Leprosy Research Agenda
Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
2 November, 2020 | Novartis International AG
Results from the Novartis Foundation-initiated Leprosy Post-Exposure Prophylaxis (LPEP) program covered more than 150,000 people across seven countries Post-exposure prophylaxis with a single dose of the antibiotic rifampicin is safe, can be integrated into different leprosy control programs, and is … More Contact tracing with prophylactic treatment could near-eliminate leprosy in a single generation, new research suggests
Project to End Child Leprosy Among Top 100 Proposals for MacArthur $100 Million Grant
26 February, 2020 | Global Partnership for Zero Leprosy
The John D. and Catherine T. MacArthur Foundation announced today that ‘End Child Leprosy by 2030: Break Transmission and Eliminate Stigma’ was one of the highest-scoring proposals, designated as the Top 100, in its 100&Change competition for a single $100 million grant to help solve one of the world’s most critical social challenges.
Workshop explores how to scale up PEP and advance research
11 November, 2019 | Global Partnership for Zero Leprosy
Leprosy Research Initiative (LRI), NLR, and the Global Partnership for Zero Leprosy (GPZL) co-hosted a workshop in Amsterdam in November 2019 to discuss issues related to post-exposure prophylaxis (PEP).
Guidelines for the diagnosis, treatment and prevention of leprosy
20 August, 2018 | World Health Organization
WHO’s Global Leprosy Programme has released the full Guidelines for the diagnosis, treatment and prevention of leprosy. The Guidelines provide state-of-the-art knowledge and evidence on leprosy diagnosis, treatment and prevention based on a public health approach in low and middle-income countries. … More Guidelines for the diagnosis, treatment and prevention of leprosy